TuHURA Biosciences, Inc. (HURA)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

TuHURA Biosciences, Inc. (HURA) is up 258.1% since the beginning of the year. At $3 per share, HURA is trading 30.5% below its 52-week high of $4. Investors who bought $1,000 worth of HURA shares 5 years ago would now be looking at an investment worth $1.

TuHURA Biosciences, Inc. (HURA) has returned 258.13% so far this year and 6.27% over the past 12 months. Over the last ten years, HURA has returned -66.00% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since Feb 22, 2013, HURA's average daily return is -0.02%, while the average monthly return is -1.36%.

Historically, 41% of months were positive and 59% were negative. The best month was Feb 2026 with a return of +212.1%, while the worst month was Oct 2023 at -81.1%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 7 months.

On a daily basis, HURA closed higher 42% of trading days. The best single day was May 31, 2019 with a return of +141.4%, while the worst single day was Oct 31, 2023 at -79.7%.

TuHURA Biosciences, Inc. has an annualized alpha of -14.44%, beta of 0.78, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since February 22, 2013.

• This stock participated in 223.92% of S&P 500 Index downside but only -75.63% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

HURA ranks 50 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the TuHURA Biosciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the TuHURA Biosciences, Inc. was 100.00%, occurring on Feb 5, 2026. The portfolio has not yet recovered.

The current TuHURA Biosciences, Inc. drawdown is 100.00%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of TuHURA Biosciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how TuHURA Biosciences, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.